News

Merkel defends slower EU vaccine rollout

February 2, 2021 03:14 AM


Twitter Share Facebook Share WhatsApp Share

German Chancellor Angela Merkel on Monday defended the European Union's troubled vaccine drive, saying there were "good reasons" the rollout had got off to a slower start than in some other countries.

Speaking after a vaccine "summit" that brought together key players, Merkel renewed a promise to offer every German citizen a vaccine by the end of September.

Merkel had convened the online talks in response to growing anger in the 27-member bloc over the sluggish rollout of Covid-19 jabs, which has been beset with delivery delays and piled political pressure on EU leaders.

"It is true that in some areas, the pace became slower, but there were good reasons for it to be slower," Merkel told reporters in Berlin. Merkel, the leader of Europe's largest economy, acknowledged that the United States, Israel and Britain were further along with their inoculations.

But she said the EU had deliberately avoided rushed emergency approvals, as seen in the UK, to bolster public "confidence" in the jabs.  The EU had also at times negotiated "for a very long time" to ensure pharma companies took on enough liability, she said. 

And the bloc chose not to sacrifice data protection, Merkel added, in a nod to Israel's deal with Pfizer/BioNTech to offer data on its inoculation campaign in exchange for doses.  German media has been scathing about the EU's troubled vaccine drive, with the top-selling Bild daily calling it a "disaster".

European Commission chief Ursula von der Leyen, a former German defence minister, has come in for particular criticism. A European source said Monday that Berlin was putting "tremendous" pressure on the Commission to improve the vaccine rollout, adding that von der Leyen's position had been "severely weakened".

Von der Leyen did not join Merkel's meeting with top German politicians, but the EU commissioners for health and the internal market did. A string of vaccine makers also took part, including Pfizer, BioNTech, AstraZeneca, Moderna, Johnson & Johnson and CureVac. "The months ahead will be challenging. We must all continue working together in solidarity to find solutions," said Health Commissioner Stella Kyriakides.



Most Read

  1. 20 passengers perish in Chilas bus plunge 20 passengers perish in Chilas bus plunge
  2. Daughters defend Bushra Bibi Daughters defend Bushra Bibi
  3. Pakistani-origin woman laid off by Elon Musk gives emotional reaction Pakistani-origin woman laid off by Elon Musk gives emotional reaction
  4. Pakistan's historic moon mission aboard China rocket blasts off Pakistan's historic moon mission aboard China rocket blasts off
  5. Parineeti Chopra's husband Raghav Chadha undergoes ‘dangerous’ eye surgery in UK Parineeti Chopra's husband Raghav Chadha undergoes ‘dangerous’ eye surgery in UK
  6. The Great Indian Kapil Show: Astonishing per-episode fees of cast revealed! The Great Indian Kapil Show: Astonishing per-episode fees of cast revealed!

Opinion

  1. PM Shehbaz Sharif, WEF and Pakistan
    PM Shehbaz Sharif, WEF and Pakistan

    By Naveed Aman Khan

  2. Employing global best practices in Pakistan-Saudi ties
    Employing global best practices in Pakistan-Saudi ties

    By Nasim Zehra

  3. PML-N smashed PTI in by-polls
    PML-N smashed PTI in by-polls

    By News Desk

  4. Riding the Digital Wave: How Technology is Rewriting the Script of Economic Prosperity
    Riding the Digital Wave: How Technology is Rewriting the Script of Economic Prosperity

    By News Desk

  5. Tax on solar energy: Govt's misplaced priorities favour powerful stakeholders over people welfare  
    Tax on solar energy: Govt's misplaced priorities favour powerful stakeholders over people welfare  

    By Manzoor Qadir

  6. Legacy of Indian military subjugation in Kashmir
    Legacy of Indian military subjugation in Kashmir

    By Dr Ghulam Nabi Fai